Stockholders' Equity (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Dec. 10, 2021 |
Oct. 21, 2021 |
Oct. 01, 2021 |
Jul. 15, 2021 |
Oct. 15, 2020 |
Jan. 30, 2020 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Stockholders' Deficit (Textual) | ||||||||
| Preferred stock, authorized | 10,000,000 | 10,000,000 | ||||||
| Preferred stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | ||||||
| Common stock, authorized | 750,000,000 | 750,000,000 | ||||||
| Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 | ||||||
| Stock based compensation (in Dollars) | $ 280,369 | |||||||
| Common stock issued | 128 | |||||||
| Tax withholdings | 2,168 | |||||||
| Purchase an aggregate, description | On May 19, 2022, the Board of Directors approved the issuance of options to purchase an aggregate of 12,778 shares of common stock to certain employees of the Company. The options have an exercise price of $26.35 per share with vesting terms of one quarter/half vesting on November 19, 2022 and the remainder monthly ratably through May 19, 2023. | The following table summarized the option activity for the years ended December 31, 2022 and 2021: | The vesting period, term and exercise price will be determined at the time of the grant. An aggregate of up to 41,176 of the Company’s common stock are reserved for issuance under the 2018 Plan. As of December 31, 2021, the Company has granted and has 21,176 options outstanding, as well as 3,929 shares of restricted common stock issued under the 2018 Plan. On July 15, 2021 the Company’s board of directors increased the number of shares of common stock authorized for grant from 41,176 to 94,118.On May 19, 2022, the Board of Directors approved the issuance of options to purchase an aggregate of 12,778 shares of common stock to certain employees of the Company. The options have an exercise price of $26.35 per share with vesting terms of one quarter/half vesting on November 19, 2022 and the remainder monthly ratably through May 19, 2023. The options will expire on May 19, 2032. The aggregate fair value of $271,324 was calculated using the Black-Scholes pricing model with the following assumptions: (i) expected life of 5 years, (ii) volatility of 115.0%, (iii) risk free rate of 2.80% (iv) dividend rate of zero, (v) stock price of $26.35, and (vi) exercise price of $26.35. The expense will be amortized over the vesting period and a total of $167,799 was recorded since issuance and through December 31, 2022. On August 19, 2022, the Board of Directors approved the issuance of options to purchase an aggregate of 303,390 shares of common stock to certain employees of the Company. The options have an exercise price of $10.20 per share with varying vesting terms through August 10, 2023. The options will expire on August 19, 2027. The aggregate fair value of $2,346,000 was calculated using the Black-Scholes pricing model with the following assumptions: (i) expected life of 5 years, (ii) volatility of 100.0%, (iii) risk free rate of 3.10% (iv) dividend rate of zero, (v) stock price of $10.20, and (vi) exercise price of $10.20. | |||||
| Dividend rate | 0.00% | |||||||
| Vesting amount (in Dollars) | $ 2,318,890 | |||||||
| Common Stock [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Shares outstanding | 1,242,647 | |||||||
| 2018 Equity Incentive Plan [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Common stock are reserved for issuance | 41,176 | |||||||
| Option outstanding | 21,176 | |||||||
| Issue of shares for the services | 3,929 | |||||||
| 2018 Equity Incentive Plan [Member] | Minimum [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Common stock authorized for grant | 41,176 | |||||||
| 2018 Equity Incentive Plan [Member] | Maximum [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Common stock authorized for grant | 94,118 | |||||||
| Option [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Remaining stock options (in Dollars) | $ 132,543 | |||||||
| Non-Executive Officer [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Granted restricted shares | 3,437 | |||||||
| Grant fair value per share (in Dollars per share) | $ 141.95 | |||||||
| Expense recorded (in Dollars) | $ 487,931 | |||||||
| Board of Directors [Member] | Option [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Aggregate fair value of options (in Dollars) | $ 2,346,000 | $ 271,324 | ||||||
| Expected life (years) | 5 years | |||||||
| Volatility rate | 115.00% | |||||||
| Risk free interest rate | 2.80% | |||||||
| Dividend rate | 0.00% | |||||||
| Share price (in Dollars per share) | $ 3.1 | $ 26.35 | ||||||
| Exercise price (in Dollars per share) | $ 26.35 | |||||||
| Purchase of aggregate share | 303,390 | |||||||
| Risk free rate | 100.00% | |||||||
| Exercise price (in Dollars per share) | $ 10.2 | |||||||
| Boris Goldstein [Member] | Option [Member] | ||||||||
| Stockholders' Deficit (Textual) | ||||||||
| Description of options vesting period | The options have an exercise price of $10.20 per share with varying vesting terms through August 10, 2023. | |||||||
| Expiration date | Aug. 19, 2027 | |||||||